U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06857253) titled 'A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subjects' on Feb. 27.
Brief Summary: This study aims to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-1301 following single and multiple dose administration in healthy subjects. The study consists of two parts (Part 1 and Part 2) with 82 subjects planned to be enrolled. Possible adjustments to sample size, treatment duration and follow-up time will depend upon emerging data.
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Hyperlipidemia
Intervention:
DRUG: HRS-1301
HRS-...